Chemokine receptor 2b inhibition provides renal protection in angiotensin II - salt hypertension. - Wikidata - wikimedia - TriplyDB

Chemokine receptor 2b inhibition provides renal protection in angiotensin II - salt hypertension.

Chemokine receptor 2b inhibition provides renal protection in angiotensin II - salt hypertension.

http://www.wikidata.org/entity/Q36800161

about

Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases Inhibition of cyclooxygenase-2 in hematopoietic cells results in salt-sensitive hypertension Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension Epoxides and soluble epoxide hydrolase in cardiovascular physiology Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension.Pentosan polysulfate treatment preserves renal autoregulation in ANG II-infused hypertensive rats via normalization of P2X1 receptor activation.The immunological basis of hypertension Mizoribine ameliorates renal injury and hypertension along with the attenuation of renal caspase-1 expression in aldosterone-salt-treated rats.Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes.Angiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease.TAK-242, a Toll-Like Receptor 4 Antagonist, Protects against Aldosterone-Induced Cardiac and Renal Injury Protective effect of TRPV1 against renal fibrosis via inhibition of TGF-β/Smad signaling in DOCA-salt hypertension.Eicosanoids and renal damage in cardiometabolic syndrome.Role of substance P in renal injury during DOCA-salt hypertension.Monocyte chemoattractant protein-1 affects migration of hippocampal neural progenitors following status epilepticus in rats.Blockade of CCR2 reduces macrophage influx and development of chronic renal damage in murine renovascular hypertension.Pentosan polysulfate preserves renal microvascular P2X1 receptor reactivity and autoregulatory behavior in DOCA-salt hypertensive rats Role of adenosine 5'-triphosphate in regulating renal microvascular function and in hypertension Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension.Immune and inflammatory role in renal disease.The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension.Clopidogrel preserves whole kidney autoregulatory behavior in ANG II-induced hypertension.The Soluble Epoxide Hydrolase Inhibitor AR9281 Decreases Blood Pressure, Ameliorates Renal Injury and Improves Vascular Function in Hypertension.Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease.Innate immunity in hypertension.Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.The role of chemokines in hypertension and consequent target organ damage.Role of the Immune System in Hypertension.Interactions Between the Immune and the Renin-Angiotensin Systems in Hypertension.High-NaCl intake impairs dynamic autoregulation of renal blood flow in ANG II-infused rats.Ets in the Kidney-Unraveling the Molecular Mechanism Underlying Renal Damage in Salt-Sensitive Hypertension.Renal effects of cytokines in hypertension.SB-216763, a GSK-3β inhibitor, protects against aldosterone-induced cardiac, and renal injury by activating autophagy.Macrophage Depletion Lowered Blood Pressure and Attenuated Hypertensive Renal Injury and Fibrosis.

P2860

Q24597172-5C598E84-71E7-4E92-89FA-2BC223ED24C3 Q27331781-B210C78B-61A9-4302-A7BE-105906970AB8 Q28390972-8AFFC12C-EC93-40CA-A730-538E78131C46 Q28396313-D1A48CDF-4A3C-47DD-82AA-AB1F0265BE09 Q28565493-6A655A8B-294A-4AF4-8EB2-5CEBD26003FB Q33570102-606125EA-9FFD-491A-8D2E-3EF333A65E91 Q33840559-30C5C76F-5595-4740-86C0-F759544E0E9A Q34683745-CCF54FE4-A0DB-4CAB-B4AD-98B7BC12CD29 Q35138708-9E6478F0-5854-4F58-8215-FEEA4B5EB46D Q35543421-498589FC-DA41-43CE-A529-E9C98E4D06E8 Q35663915-40CDA3CE-4A8B-4124-AE4A-840E6136C538 Q35837781-6F123AEE-0948-4165-985F-E3CA07EC78CD Q35876750-7E4FEDE5-3BC2-49F4-A2BC-DDEB5AB2C655 Q35947602-4F9B4AF4-BE32-4E3A-B79A-1D91A7605FD4 Q36439613-8CE8B0A2-DB18-4B33-AA0D-B7B3186A33B6 Q36585380-D519E7CC-BD71-45C0-BC12-B08154A8E9D5 Q36638400-68093501-D98E-49F0-90C0-B55AB3B1EB43 Q36698733-095F3166-CF61-4A7E-A552-D5F0FE9D7D91 Q37062376-5B99F481-622F-41A3-ACF6-2928BA5D7BBB Q37071386-6C8CC3D6-8513-4CA3-ADDE-5FFD56FB40A0 Q37243199-7A22EE5F-A4F5-4850-99E1-29C15F64D36C Q37433886-3D73A899-E7E3-4FD9-A04E-AAE1262DDFA4 Q37629205-BEB09AD6-613F-4372-8143-8A6BFA98DF62 Q37689880-0683FE9F-ED94-4ACD-899D-F1DA8E9D1313 Q37960812-3F051189-1B81-46CA-82EF-643E60D9EB9F Q38177167-FFB959A2-0B7F-4648-A732-F8752CFF13F5 Q38726039-7F8D43FB-0313-4628-BB31-81E8B6870F51 Q38747937-A0766B18-47DC-401B-8F95-618B669DA311 Q39342382-7164A7BC-00DF-4B5B-833A-F0E9B56B4C8D Q42419570-C91C5A0C-2382-4680-8B25-CDCB1641873C Q42933571-5256FA31-85CD-457C-9D20-5A3BAE51C3A3 Q45070233-C4080297-164B-43BB-B56F-52EC0223FDA1 Q49997121-7407270F-4BA4-4198-B614-2E6FD7A2C480 Q55246908-FB35DB85-36EE-4DA3-BA17-00527B144729 Q55280575-B7CF8D39-F14E-4CBE-9832-E04AB3FD64C9

P2860

Chemokine receptor 2b inhibition provides renal protection in angiotensin II - salt hypertension.

http://www.wikidata.org/entity/Q36800161

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Chemokine receptor 2b inhibiti ...... tensin II - salt hypertension.

@ast

Chemokine receptor 2b inhibiti ...... tensin II - salt hypertension.

@en

type

label

Chemokine receptor 2b inhibiti ...... tensin II - salt hypertension.

@ast

Chemokine receptor 2b inhibiti ...... tensin II - salt hypertension.

@en

prefLabel

Chemokine receptor 2b inhibiti ...... tensin II - salt hypertension.

@ast

Chemokine receptor 2b inhibiti ...... tensin II - salt hypertension.

@en

P1433

Q36800161-4E77153F-2B51-4035-8E67-B2D8DEBB8D18

P1476

Q36800161-7B838C05-C633-4E4A-BCE8-FAD42F2A6EC0

P2093

Q36800161-099A9432-858C-4D5F-890F-1BEFEDC0A88A

Q36800161-2EA3E9D1-46F9-40F8-B102-BE614A2DA007

Q36800161-3C4B52F7-5160-40DE-AE32-0AF5380E6C8B

Q36800161-73BE9B3D-7955-4F9E-B61B-C09CB4448511

Q36800161-773EB500-E267-4A4A-B5D9-195BF67B298B

Q36800161-E4B4022C-451D-4752-8E8B-D920697B1C3C

Q36800161-F3569A47-A94D-49B9-B3FD-B9EC4510144C

P2860

Q36800161-0836580A-8DFB-48C4-8A73-6DF890D14639

Q36800161-147355D5-7108-45C0-9B9E-0FC65FDEA4A9

Q36800161-14EB0AA1-87BA-4F60-BC31-E77D2649D5A2

Q36800161-1B3B8188-6E1B-432E-94B3-497A1648AB3B

Q36800161-216C9296-7C72-407A-9195-6B0D3791C912

Q36800161-22480260-BAE6-4D41-A437-E6CFFF2764F1

Q36800161-33FC0CA8-D8AE-4420-8BA6-FFC54B0BF862

Q36800161-46102008-D8AC-425C-A07A-5AB7BF2C099A

Q36800161-4D63EA76-E03D-45D8-9A84-8BA4EAB158C2

Q36800161-4DECCB98-9196-42E3-9CFB-FCCB80D6C2FF

P304

Q36800161-0BA2F98D-9FB0-40B9-B970-9B39E9967816

P31

Q36800161-52926557-1141-420C-BB9F-9E253416076C

P356

Q36800161-BDC18360-8204-4E25-8971-77E26BA9CC9D

P407

Q36800161-86CDB742-4FBA-49D1-A890-752598985028

P433

Q36800161-58B0269A-C9A9-48AC-B76A-4357293DADD8

P478

Q36800161-1FA9B72E-6B15-4618-A8BD-99CA9C7DF226

P50

Q36800161-F3850256-4D3D-4E77-BE74-67889C9C9514

P577

Q36800161-07C3DB55-E28E-45CD-BDE8-86415E6747FB

P698

Q36800161-EE99BA85-276C-4B63-9327-5377F0BAEE0D

P932

Q36800161-6649F7A5-88C8-4D94-9344-0E8D884CBAA2

P356

HYPERTENSIONAHA.107.098806

P1433

P1476

Chemokine receptor 2b inhibiti ...... otensin II - salt hypertension

@en

P2093

Aarthi Sridhar

http://www.w3.org/2001/XMLSchema#string

Ahmed A Elmarakby

http://www.w3.org/2001/XMLSchema#string

Anthony K Cook

http://www.w3.org/2001/XMLSchema#string

David M Pollock

http://www.w3.org/2001/XMLSchema#string

Edward W Inscho

http://www.w3.org/2001/XMLSchema#string

Jeffrey E Quigley

http://www.w3.org/2001/XMLSchema#string

Jeffrey J Olearczyk

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle

New role for epoxyeicosatrienoic acids as anti-inflammatory mediators

CCR2 modulates inflammatory and metabolic effects of high-fat feeding

Vascular inflammation and the renin-angiotensin system.

The strategy of blocking the chemokine system to combat disease.

Proinflammatory actions of angiotensins.

Chemokine receptors: multifaceted therapeutic targets.

Adaptations of the renal microcirculation to hypertension.

Blockade of CCR2 ameliorates progressive fibrosis in kidney.

MCP-1 induces inflammatory activation of human tubular epithelial cells: involvement of the transcription factors, nuclear factor-kappaB and activating protein-1.

P304

1069-1076

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/HYPERTENSIONAHA.107.098806

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17938380

http://www.w3.org/2001/XMLSchema#string

P932

2491337

http://www.w3.org/2001/XMLSchema#string